M. D. Anderson Cancer Center Postdoc Faked Results Of Novartis AG (NVS) Brain Tumor Study
More Drama At Sarepta Therapeutics (SRPT) As Chairman Of The Board Abruptly Steps Down, Interim Chairman Named
Ex-Eli Lilly and Company (LLY) Scientists Fighting Fraud Charges Now Battle Over Leak Of Internal Documents
Biota Pharmaceuticals, Inc. (BOTA) Stock Crashes As Influenza Drug Laninamivir Octanoate Fails Mid-Stage Trial; Stock Down -20.54% At 11:37AM ET
As Sanofi (France) (SAN.PA) Pushes to Grow Faster, A Top U.S. Exec Is Leaving
VC Firm Venrock Locks In $450 Million To Invest In Tech And Life Sciences Startups
Novartis AG (NVS) Malaria Pill KAE609 Shows Promise As Best Drugs Fail
Loxo Oncology (LOXO) Prices Upsized IPO At Midpoint Of The Range, $13 A Share
FDA Green Lights Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly and Company (LLY)'s Jardiance For Type 2 Diabetes
Solasia Pharma K.K. Grabs Global Rights To ZIOPHARM Oncology, Inc. (ZIOP.OB)'s Zinapar For Up To $72.2 Million
Genmab A/S (GEN.CO), GlaxoSmithKline (GSK)'s Ofatumumab Meets Primary Endpoint In Late-Stage Study
As The Pursuit For Allergan Inc. (AGN) Continues, Valeant Pharmaceuticals International (VRX) Hunts For More Deals—Including Contact Lenses
Benefit Of Baxter International, Inc. (BAX)'s Immune Therapy Outweighs Risk: FDA Panel
AstraZeneca PLC (AZN) Touts 2nd Quarter Results After Fending Off Pfizer Inc. (PFE), CEO And Investors Rejoice
Google Inc. Exec Joins Illumina, Inc. (ILMN)'s Board Of Directors
Regeneron Pharmaceuticals, Inc. (REGN), Sanofi (France) (SAN.PA) Bag BioMarin Pharmaceutical Inc. (BMRN)'s Special FDA Priority Review Voucher For $67.5 Million
Novartis AG (NVS) Apologizes For Not Disclosing Side-Effects Of Leukemia Drugs Sooner
Menlo Park's Avalanche Biotechnologies (AAVL) Rolls Onto Nasdaq, Raises $102 Million For Its IPO
See All News >
Too Much Hype Doomed Once-Successful Wyeth (WYE) CEO
FDA Will Regulate Thousands Of Cancer, Genetic, And Other Diagnostic
Lucrative Big Pharma Deals Found At All Stages Of Scientific Research, Trinity College Dublin Reveals
Billionaire Doctor-Turned Entrepreneur Buys World's Most Powerful DNA Sequencer
UK Startup InoCardia Creating Animal-Free Drug Testing
"Rewired" Mice Show Signs Of Longer Lives With Fewer Illnesses, The Wistar Institute Study
Study Explains How Some People Function On Very Little Sleep, Children's Hospital of Philadelphia Reveals
Birth Control Pills May Double Breast Cancer Risk, Fred Hutchinson Cancer Research Center Study
University of Texas Study: Noise-Induced Hearing Loss Alters Brain Responses To Speech
National University of Singapore (NUS) Study Shows Effectiveness Of Common Anti-Malarial Drug In Controlling Asthma
UK To Become World Number One In DNA Testing With Plan To Revolutionize Fight Against Cancer And Rare Diseases
Allergan Inc. (AGN) Layoffs: Employees Tell Their Side Of The Story
Puma Biotechnology (PBYI)'s Overnight Billionaire On One Of His Keys To Success
Psychologists Discover A Surprising Thing Happens To Kids Who Read Harry Potter, University of Modena Reveals
Three Things To Take Away From Amgen (AMGN)'s Big Restructuring
Gilead Sciences, Inc. (GILD) Popular Amongst Latest 13F Filers
BioPharm Executive: Have Drugs Finally Been Priced Too High?
Insiders Reveal Valeant Pharmaceuticals International (VRX)'s Cost Cutting May Have Gone Too Far
See All News >
Regeneron Pharmaceuticals, Inc. (REGN), Sanofi (France) (SAN.PA) Bag BioMarin Pharmaceutical Inc. (BMRN)'s Special FDA Priority Review Voucher For $67.5 Million
Novartis AG (NVS) Apologizes For Not Disclosing Side-Effects Of Leukemia Drugs Sooner
Menlo Park's Avalanche Biotechnologies (AAVL) Rolls Onto Nasdaq, Raises $102 Million For Its IPO
Amgen (AMGN) Eliminating Up To 2,900 Jobs; Will Shutter Seattle, Bothell Sites
Allergan Inc. (AGN) Layoffs: Employees Tell Their Side Of The Story
Flailing Dendreon Corporation (DNDN) Brings In Ex-Johnson & Johnson (JNJ) Exec For Top CEO Post
Puma Biotechnology (PBYI)'s Overnight Billionaire On One Of His Keys To Success
Psychologists Discover A Surprising Thing Happens To Kids Who Read Harry Potter, University of Modena Reveals
AstraZeneca PLC (AZN) Steps Up Push Into Cancer Immunotherapy, Falls Behind Rivals Such As Bristol-Myers Squibb Company (BMY), Merck & Co., Inc. (MRK), And Roche (RHHBY)
Three Things To Take Away From Amgen (AMGN)'s Big Restructuring
Gilead Sciences, Inc. (GILD) Popular Amongst Latest 13F Filers
GlaxoSmithKline (GSK) May Separate Businesses
BioPharm Executive: Have Drugs Finally Been Priced Too High?
Amid Cuts, Amgen (AMGN) To Add Jobs In Cambridge, Massachusetts
Insiders Reveal Valeant Pharmaceuticals International (VRX)'s Cost Cutting May Have Gone Too Far
Catalent Pharma Solutions (CTLT) Prices IPO At Midpoint Range, Raises $871 Million
Tree Nuts May Fight Metabolic Disease, Diabetes, St. Michael's Hospital Study
FDA Approves Boehringer Ingelheim Pharmaceuticals, Inc.'s Once-A-Day Inhaler Drug Striverdi For Chronic Lung Disease Patients
See All News >
//-->